<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent studies have demonstrated that blockade of the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor with <z:chebi fb="0" ids="6541">losartan</z:chebi> decreases aortic damage in an animal model of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (a KI mouse model with a pathogenic mutation in the gene coding for fibrillin-1) </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To demonstrate a beneficial effect of <z:chebi fb="0" ids="6541">losartan</z:chebi> on <z:hpo ids='HP_0001724'>aortic dilatation</z:hpo> when added to optimal therapy in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This is a multicentre, randomized, placebo-controlled, double-blind, clinical trial with a 2-year inclusion period and a 3-year follow-up period </plain></SENT>
<SENT sid="3" pm="."><plain>Aortic root diameter will be measured using two-dimensional echocardiography </plain></SENT>
<SENT sid="4" pm="."><plain>Secondary endpoints will include incidence of <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>, aortic root surgery, <z:hpo ids='HP_0011420'>death</z:hpo>, quality of life, tolerance and compliance with treatments </plain></SENT>
<SENT sid="5" pm="."><plain>We aim to enroll a total of 300 patients aged &gt; or =10 years who fulfil the Ghent criteria for <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Analyses will be based on intention to treat </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The results of this clinical trial could lead to profound modification of the management of aortic risk and complications in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and possibly in patients with thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> of other aetiologies </plain></SENT>
</text></document>